325 related articles for article (PubMed ID: 24512328)
21. The Antagonism between the Murine Gammaherpesvirus Protein Kinase and Global Interferon Regulatory Factor 1 Expression Shapes the Establishment of Chronic Infection.
Jondle CN; Sylvester PA; Schmalzriedt DL; Njoya K; Tarakanova VL
J Virol; 2022 Oct; 96(20):e0126022. PubMed ID: 36169331
[TBL] [Abstract][Full Text] [Related]
22. Post-transplant lymphoproliferative disorders: implications for acquired immunodeficiency syndrome-associated malignancies.
Swinnen LJ
J Natl Cancer Inst Monogr; 2001; (28):38-43. PubMed ID: 11158205
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Sack FU; Schnabel P; Schnitzler P; Katus HA; Dengler TJ
Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
[TBL] [Abstract][Full Text] [Related]
24. Multifaceted roles for STAT3 in gammaherpesvirus latency revealed through
Hogan CH; Owens SM; Reynoso GV; Liao Y; Meyer TJ; Zelazowska MA; Liu B; Li X; Grosskopf AK; Khairallah C; Kirillov V; Reich NC; Sheridan BS; McBride KM; Gewurz BE; Hickman HD; Forrest JC; Krug LT
mBio; 2024 Feb; 15(2):e0299823. PubMed ID: 38170993
[TBL] [Abstract][Full Text] [Related]
25. Latent gammaherpesvirus exacerbates arthritis through modification of age-associated B cells.
Mouat IC; Morse ZJ; Shanina I; Brown KL; Horwitz MS
Elife; 2021 Jun; 10():. PubMed ID: 34080972
[TBL] [Abstract][Full Text] [Related]
26. The Interaction between Tegument Proteins ORF33 and ORF45 Plays an Essential Role in Cytoplasmic Virion Maturation of a Gammaherpesvirus.
Jia X; Sun L; Shen S; Zhang Z; Lyu Y; Guo H; Deng H
J Virol; 2022 Nov; 96(22):e0107322. PubMed ID: 36300940
[TBL] [Abstract][Full Text] [Related]
27. Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus.
Swaminathan S
Semin Hematol; 2003 Apr; 40(2):107-15. PubMed ID: 12704587
[TBL] [Abstract][Full Text] [Related]
28. Murine Gammaherpesvirus 68: A Small Animal Model for Gammaherpesvirus-Associated Diseases.
Dong S; Forrest JC; Liang X
Adv Exp Med Biol; 2017; 1018():225-236. PubMed ID: 29052141
[TBL] [Abstract][Full Text] [Related]
29. Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray.
Zheng D; Wan J; Cho YG; Wang L; Chiou CJ; Pai S; Woodard C; Zhu J; Liao G; Martinez-Maza O; Qian J; Zhu H; Hayward GS; Ambinder RF; Hayward SD
J Infect Dis; 2011 Dec; 204(11):1683-91. PubMed ID: 21990424
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes.
Bräuninger A; Spieker T; Mottok A; Baur AS; Küppers R; Hansmann ML
Eur J Immunol; 2003 Jun; 33(6):1593-602. PubMed ID: 12778477
[TBL] [Abstract][Full Text] [Related]
31. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
32. Induction of protective immunity against murine gammaherpesvirus 68 infection in the absence of viral latency.
Jia Q; Freeman ML; Yager EJ; McHardy I; Tong L; Martinez-Guzman D; Rickabaugh T; Hwang S; Blackman MA; Sun R; Wu TT
J Virol; 2010 Mar; 84(5):2453-65. PubMed ID: 20015983
[TBL] [Abstract][Full Text] [Related]
33. EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.
Cirone M
Viruses; 2018 Oct; 10(11):. PubMed ID: 30384495
[TBL] [Abstract][Full Text] [Related]
34. Post-transplant lymphoproliferative disease in pediatric solid organ transplant recipients.
Wistinghausen B; Gross TG; Bollard C
Pediatr Hematol Oncol; 2013 Sep; 30(6):520-31. PubMed ID: 23802715
[TBL] [Abstract][Full Text] [Related]
35. Cancers associated with human gammaherpesviruses.
Wen KW; Wang L; Menke JR; Damania B
FEBS J; 2022 Dec; 289(24):7631-7669. PubMed ID: 34536980
[TBL] [Abstract][Full Text] [Related]
36. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.
Merlino C; Cavallo R; Bergallo M; Giacchino F; Bollero C; Negro Ponzi A; Cavallo G
New Microbiol; 2003 Apr; 26(2):141-9. PubMed ID: 12737195
[TBL] [Abstract][Full Text] [Related]
37. Post-transplant lymphoproliferative disorder.
Basgoz N; Preiksaitis JK
Infect Dis Clin North Am; 1995 Dec; 9(4):901-23. PubMed ID: 8747772
[TBL] [Abstract][Full Text] [Related]
38. Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection.
Ahya VN; Douglas LP; Andreadis C; Arnoldi S; Svoboda J; Kotloff RM; Hadjiliadis D; Sager JS; Woo YJ; Pochettino A; Schuster SJ; Stadtmauer EA; Tsai DE
J Heart Lung Transplant; 2007 Aug; 26(8):839-44. PubMed ID: 17692789
[TBL] [Abstract][Full Text] [Related]
39. Identifying predictive factors for posttransplant lymphoproliferative disease in pediatric solid organ transplant recipients with Epstein-Barr virus viremia.
Weintraub L; Weiner C; Miloh T; Tomaino J; Joashi U; Benchimol C; Strauchen J; Roth M; Wistinghausen B
J Pediatr Hematol Oncol; 2014 Nov; 36(8):e481-6. PubMed ID: 24878618
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology and morbidity of Epstein-Barr virus infection in pediatric renal transplant recipients: a multicenter, prospective study.
Höcker B; Fickenscher H; Delecluse HJ; Böhm S; Küsters U; Schnitzler P; Pohl M; John U; Kemper MJ; Fehrenbach H; Wigger M; Holder M; Schröder M; Billing H; Fichtner A; Feneberg R; Sander A; Köpf-Shakib S; Süsal C; Tönshoff B
Clin Infect Dis; 2013 Jan; 56(1):84-92. PubMed ID: 23042966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
